In this ISSUE

TransCelerate Establishes Technology Common Protocol Template and Collaborates with the FDA/NIH

Acknowledging Cycle Time Impact from Protocol Amendments

CTMS: What You Should Know

Industry Survey

Anonymous RBM Barriers Survey

This anonymous survey focusing on RBM, including Barriers to Adoption is looking for the participation of industry professionals to use their responses as part of an expert advisory panel to the FDA.
... /Read more/

Scientific Advice with Regulators – An Essential Tool in Early Drug Development
Live Webcast- Europe: Thursday, March 29, 2018 at 3:00pm CEST, North America: Tuesday, April 17 at 11:00am EDT

Clinical Trial Concepts

Clinical Trial Update from CROWN Congress

During the CROWN congress, there was discussion on CRO acquisition and consolidation, growing interest in the use of Blockchain technology in clinical trials, and new patient engagement methodologies.
... /Read more/

The Benefits of a Data-driven Approach to Feasibility
Live Webcast: Tuesday, March 20 at 11:00am EDT

Clinical Trial News

Latest Business and People News

Updated employee announcements, business news, awards, and recognition in the industry today.
... /Read more/

Regulatory Authorities

Are Safety Signals Overlooked in Clinical Trials?

In this interview, Jennifer Prichard, MD, Medical Monitor at Atlantic Research Group, and Hunter Walker, CTO at Atlantic Research Group will discuss challenges with existing medical monitoring processes, and how new technologies can help improve efficiency.
... /Read more/

Patient Centricity

FDA Strives to Maintain Gains in Speeding More Breakthroughs to Patients

Now the challenge to FDA and to sponsors is to maintain the high level of support for research, discovery, and regulatory flexibility underpinning these gains, writes Jill Wechsler.
... /Read more/

Calendar

/ EU Clinical Trial Regulation Summit 3/06-3/07 /

/ ADF 2018 - Abuse Deterrent Formulations Summit 3/13-3/14 /

/ Optimization of Cell and Gene Therapy Production 3/26-3/27 /

/ Imaging in Clinical Trials 3/28-3/29 /

Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Strategy
On Demand

Learn more

Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com

website / blog / advertise / subscribe